Dronabinol and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dronabinol (dronabinol) and Bumetanide (bumetanide). Common drug interactions include fatigue among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Dronabinol and Bumetanide. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Dronabinol?

Dronabinol has active ingredients of dronabinol. eHealthMe is studying from 5,453 Dronabinol users. Check the latest studies of Dronabinol.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.



On Jul, 26, 2026

31 people who take Dronabinol and Bumetanide together, and have interactions are studied.

Dronabinol and Bumetanide drug interactions.

What are the common drug interactions of Dronabinol and Bumetanide, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Dry skin
  3. Abdominal distension
  4. Trigger finger
  5. Chronic kidney disease
  6. Death
  7. Dyspnoea (difficult or laboured respiration)
  8. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  9. Nausea (feeling of having an urge to vomit)
  10. Oral discomfort (pain or irritation in mouth)

male:

  1. Death
  2. Liver injury
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Brain neoplasm (tumour of brain)
  5. Hyperbilirubinaemia (excess of bilirubin in the blood)
  6. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  7. Second primary malignancy (after getting cure a cancer, a new cancer development)
  8. Septic arthritis staphylococcal (bacterial blood infection spreads to joint caused by staphylococcus)
  9. Urinary tract infection
  10. Blood pressure decreased

What are the common drug interactions of Dronabinol and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Death
  2. Dyspnoea (difficult or laboured respiration)
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Flushing (the warm, red condition of human skin)

30-39:

n/a

40-49:

  1. Folliculitis (infection of hair root)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Chronic kidney disease
  3. Dyspnoea (difficult or laboured respiration)
  4. Nausea (feeling of having an urge to vomit)
  5. Oxygen saturation decreased

60+:

  1. Fatigue (feeling of tiredness)
  2. Dry skin
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Oral discomfort (pain or irritation in mouth)
  5. Pneumonia
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Brain neoplasm (tumour of brain)
  8. Hyperbilirubinaemia (excess of bilirubin in the blood)
  9. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  10. Second primary malignancy (after getting cure a cancer, a new cancer development)

What are the existing conditions these people have? *

  1. Pain: 5 people, 16.13%
  2. Neoplasm Malignant (cancer tumour): 5 people, 16.13%
  3. Nausea (feeling of having an urge to vomit): 4 people, 12.90%
  4. Gout (uric acid crystals building up in the body): 4 people, 12.90%
  5. Insomnia (sleeplessness): 4 people, 12.90%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.90%
  7. High Blood Pressure: 4 people, 12.90%
  8. Hypersensitivity: 3 people, 9.68%
  9. Multiple Myeloma (cancer of the plasma cells): 3 people, 9.68%
  10. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Dronabinol and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dronabinol and Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dronabinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dronabinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dronabinol and bumetanide (the active ingredients of Dronabinol and Bumetanide, respectively), and Dronabinol and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: